Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
September 19th, 2014
Near-infrared fluorescence (NIRF) imaging may improve therapeutic outcome of breast cancer surgery by enabling intraoperative tumor localization and evaluation of surgical margin status. Using tissue-simulating breast phantoms containing fluorescent tumor-simulating inclusions, potential clinical applications of NIRF imaging in breast cancer patients can be assessed for standardization and training purposes.
Overview
This study explores the application of near-infrared fluorescence (NIRF) imaging in breast conserving surgery. By utilizing tissue-simulating breast phantoms with fluorescent tumor-like inclusions, the research aims to enhance intraoperative tumor localization and assess surgical margin status.
Key Study Components
Area of Science
- Oncology
- Medical Imaging
- Fluorescence Techniques
Background
- Breast cancer surgery requires precise tumor localization.
- Intraoperative evaluation of surgical margins is critical for patient outcomes.
- Near-infrared fluorescence imaging may provide real-time guidance during surgery.
- Tissue-simulating phantoms can help in training and standardization of imaging techniques.
Purpose of Study
- To simulate NIRF imaging applications in breast conserving surgery.
- To create tumor-like fluorescent inclusions for testing imaging techniques.
- To evaluate the effectiveness of NIRF in guiding surgical procedures.
Methods Used
- Creation of tumor-like fluorescent inclusions of varying sizes and shapes.
- Integration of these inclusions into breast-shaped phantoms.
- Application of NIRF imaging to guide intraoperative tumor localization.
- Scanning of surgical cavity margins for residual disease post-excision.
Main Results
- NIRF imaging successfully localized fluorescent tumor-like inclusions.
- The method allowed for effective evaluation of surgical margins.
- Results indicate potential for improved surgical outcomes in breast cancer treatment.
- Phantom models provide a valuable tool for training and standardization.
Conclusions
- NIRF imaging can enhance intraoperative decision-making in breast cancer surgery.
- Use of tissue-simulating phantoms is beneficial for clinical training.
- Further studies are needed to validate clinical applications in live surgeries.
Frequently Asked Questions
Executive Industry Relevance
Standardized tissue-simulating phantoms for near-infrared fluorescence (NIRF) imaging enable robust preclinical evaluation of intraoperative tumor localization and surgical margin assessment technologies. This approach supports predictive confidence in imaging-guided breast cancer surgery and informs translational readiness for real-time surgical guidance platforms. Integrating phantom-based validation into the discovery-to-preclinical continuum de-risks technology transfer and cross-site reproducibility.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic interrogation of NIRF imaging performance in controlled, tissue-mimicking environments.
- Supports mechanistic de-risking by isolating optical and biological variables affecting tumor detectability.
- Facilitates functional validation of imaging agents and device prototypes prior to in vivo studies.
Screening & Assay Development
- Provides a reproducible platform for quantitative assessment of imaging sensitivity and margin detection accuracy.
- Standardizes assay conditions for benchmarking imaging system performance across development cycles.
- Enables scalable training and protocol optimization for imaging-guided surgical workflows.
Translational & Preclinical Research
- Aligns imaging system outputs with clinically relevant endpoints such as margin status and tumor localization depth.
- Supports continuity from benchtop validation to preclinical and clinical feasibility studies.
- De-risks translational advancement by identifying technical limitations, such as photon penetration depth, early in development.
Pipeline & Workflow Integration
This phantom-based NIRF imaging validation fits within the early discovery to preclinical workflow, bridging device prototyping, imaging agent assessment, and translational readiness for intraoperative guidance systems.
- Discovery Biology: Enables hypothesis testing on imaging agent detectability and margin delineation in a controlled setting.
- Screening: Provides quantitative, reproducible outputs for imaging system benchmarking and optimization.
- Analytics: Delivers measurable readouts on tumor localization accuracy and margin assessment sensitivity.
- Translational Research: Facilitates alignment of imaging performance with surgical and pathological endpoints relevant to clinical adoption.
- Enterprise Reuse: Establishes a reusable, standardized platform for iterative device and agent validation across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in imaging-guided surgical interventions and reduces mechanistic ambiguity.
- Operational Value: Drives standardization, reproducibility, and scalability in imaging system evaluation and training.
- Strategic Value: Informs go/no-go decisions for imaging agent and device advancement, optimizing R&D investment.
- Portfolio Impact: Supports risk-adjusted prioritization of imaging-guided surgical technologies for clinical translation.
Implementation Considerations
- Requires expertise in optical imaging, phantom fabrication, and quantitative image analysis.
- Needs access to NIRF imaging instrumentation and standardized phantom production materials.
- Demands cross-team alignment on imaging protocols and performance metrics for reproducibility.
- Adaptation may be needed for different tissue types or imaging agent properties.
- Limited photon penetration depth constrains evaluation of deep-seated tumor models.
Biopharma FAQs
Chapters in this video
0:05
Title
1:38
Create Silicone Molds for Tumor-simulating Inclusions
2:58
Create Fluorescent Inclusions
4:49
Create Breast Phantoms
7:15
Simulation of NIRF Imaging Applications in Breast Cancer Surgery
9:11
Results: Different Applications of NIRF Imaging in Breast-conserving Surgery as Assessed on Tissue-like Breast Phantoms
10:30
Conclusion
